EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells.

MLA

Huttunen, Jasmin, et al. “EP300/CREBBP Acetyltransferase Inhibition Limits Steroid Receptor and FOXA1 Signaling in Prostate Cancer Cells.” Cellular and Molecular Life Sciences : CMLS, vol. 81, no. 1, Apr. 2024, p. 160. EBSCOhost, https://doi.org/10.1007/s00018-024-05209-z.

APA

Huttunen, J., Aaltonen, N., Helminen, L., Rilla, K., & Paakinaho, V. (2024). EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells. Cellular and Molecular Life Sciences : CMLS, 81(1), 160. https://doi.org/10.1007/s00018-024-05209-z

Chicago

Huttunen, Jasmin, Niina Aaltonen, Laura Helminen, Kirsi Rilla, and Ville Paakinaho. 2024. “EP300/CREBBP Acetyltransferase Inhibition Limits Steroid Receptor and FOXA1 Signaling in Prostate Cancer Cells.” Cellular and Molecular Life Sciences : CMLS 81 (1): 160. doi:10.1007/s00018-024-05209-z.